Heparin vs pentasaccharide
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 198 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Heparin showed no clear difference in DVT compared with pentasaccharide (low certainty).
It is very uncertain whether heparin changes adverse events (thrombocytopenia) compared with pentasaccharide (very low certainty).
Heparin started before showed no clear difference in VTE compared with after the surgical procedure (low certainty).
It is very uncertain whether heparin started before changes major bleeding compared with after the surgical procedure (very low certainty).
The review found no eligible studies for this question.
Higher‐dose heparin showed no clear difference in major bleeding compared with standard‐dose heparin (low certainty).
Heparin started before showed no clear difference in DVT compared with after the surgical procedure (low certainty).
The review found no eligible studies for this question.
Combined mechanical and pharmacological prophylaxis may leads to lower VTE compared with mechanical prophylaxis alone (low certainty).
The review found no eligible studies for this question.
Combined mechanical and pharmacological prophylaxis may leads to lower DVT compared with mechanical prophylaxis alone (low certainty).
The review found no eligible studies for this question.